Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
47.2M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
31M
-
Shares change
-
-746K
-
Total reported value, excl. options
-
$52.7M
-
Value change
-
-$1.13M
-
Put/Call ratio
-
0.45
-
Number of buys
-
10
-
Number of sells
-
-12
-
Price
-
$1.70
Significant Holders of ESSA Pharma Inc. - Common Shares (EPIX) as of Q2 2025
44 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares as of Q2 2025.
ESSA Pharma Inc. - Common Shares (EPIX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31M shares
of 47.2M outstanding shares and own 65.56% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.75M shares), TANG CAPITAL MANAGEMENT LLC (4.3M shares), BML Capital Management, LLC (4.22M shares), MORGAN STANLEY (4.21M shares), Soleus Capital Management, L.P. (2.26M shares), Opaleye Management Inc. (2.21M shares), Pfizer Inc (1.68M shares), BANK OF AMERICA CORP /DE/ (628K shares), Aldebaran Capital, LLC (579K shares), and DLD Asset Management, LP (315K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.